A one-year multicentre, international, randomised, double-blind study with comparison of benfluorex (150 mg od to 150 mg tid) versus pioglitazone (30 mg od to 45 mg od) in combination with sulfonylurea administered orally for the treatment of type 2 diabetes.

Registry ID

EUCTR2005-004798-60

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

I.R.I.S. Institut de Recherches Internationales Servier

Start date

2006-04-10

Completion date

2009-01-15

Last update

2026-08-16

Conditions

• Type II Diabetes

Summary

Compare the efficacy of benfluorex and pioglitazone in type 2 diabetic patients on top of sulfonylurea over one year of treatment.

Locations

• , , Czechia
• , , Germany

Related clinical trials

• The GRoceries Aimed at Increasing Nutrition Study
• Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
• Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
• Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
• Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study.

View on source registry